Bellus Stock Today

BLU
 Stock
  

USD 10.23  0.35  3.31%   

Market Performance
4 of 100
Odds Of Distress
Less than 49
Bellus Health is selling for under 10.23 as of the 25th of September 2022; that is -3.31 percent decrease since the beginning of the trading day. The stock's last reported lowest price was 10.11. Bellus Health has 49 percent odds of going through some form of financial distress in the next two years and did not have a very good performance for investor during the last 90 trading days. Equity ratings for Bellus Health are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 5th of October 2020 and ending today, the 25th of September 2022. Click here to learn more.
BELLUS Health Inc., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of refractory chronic cough and other cough hypersensitivity indications. The company was incorporated in 1993 and is based in Laval, Canada. Bellus Health operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. The company has 103.35 M outstanding shares of which 15.53 M shares are currently shorted by investors with about 9.72 days to cover. More on Bellus Health

Moving together with Bellus Health

+0.78DISWalt Disney Fiscal Year End 9th of November 2022 PairCorr
Follow Valuation Odds of Bankruptcy
Check how we calculate scores

Bellus Health Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Bellus Health's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Bellus Health or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Bellus Health has very high historical volatility over the last 90 days
Bellus Health has high likelihood to experience some financial distress in the next 2 years
The company reported the last year's revenue of 16 K. Reported Net Loss for the year was (69.83 M) with profit before taxes, overhead, and interest of 16 K.
Bellus Health has about 233.97 M in cash with (60.13 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.19.
Over 90.0% of the company shares are held by institutions such as insurance companies
Latest headline from www.bnnbloomberg.ca: The Daily Chase U.S. dollar climbs Kinross plans share buybacks - BNN Bloomberg
Joint CEO, Executive DirectorMark Levy
Average Analyst Recommendation
Analysts covering Bellus Health report their recommendations after researching Bellus Health's financial statements, talking to executives and customers, or listening in on Bellus Health's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Bellus Health. The Bellus consensus assessment is calculated by taking the average forecast from all of the analysts covering Bellus Health.
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of Bellus Health's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Bellus Health (BLU) is traded on NASDAQ Exchange in USA and employs 40 people. The company currently falls under 'Mid-Cap' category with total capitalization of 1.08 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Bellus Health's market, we take the total number of its shares issued and multiply it by Bellus Health's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. Bellus Health runs under Healthcare sector within Biotechnology industry. The entity has 103.35 M outstanding shares of which 15.53 M shares are currently shorted by investors with about 9.72 days to cover. Bellus Health has about 233.97 M in cash with (60.13 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.19.
Check Bellus Health Probability Of Bankruptcy
Ownership
Bellus Health retains a total of 103.35 Million outstanding shares. The majority of Bellus Health outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Bellus Health to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Bellus Health. Please pay attention to any change in the institutional holdings of Bellus Health as this could imply that something significant has changed or about to change at the company. Also note that nearly two million sixty-seven thousand invesors are currently shorting Bellus Health expressing very little confidence in its future performance.

Ownership Allocation (%)

Check Bellus Ownership Details

Bellus Stock Price Odds Analysis

Attributed to a normal probability distribution, the odds of Bellus Health jumping above the current price in 90 days from now is about 58.07%. The Bellus Health probability density function shows the probability of Bellus Health stock to fall within a particular range of prices over 90 days. Considering the 90-day investment horizon the stock has a beta coefficient of 1.1733 suggesting as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Bellus Health will likely underperform. Additionally, the company has an alpha of 0.526, implying that it can generate a 0.53 percent excess return over DOW after adjusting for the inherited market risk (beta).
  Odds Below 10.23HorizonTargetOdds Above 10.23
41.79%90 days
 10.23 
58.07%
Based on a normal probability distribution, the odds of Bellus Health to move above the current price in 90 days from now is about 58.07 (This Bellus Health probability density function shows the probability of Bellus Stock to fall within a particular range of prices over 90 days) .

Bellus Stock Institutional Holders

Institutional Holdings refers to the ownership stake in Bellus Health that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Bellus Health's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Bellus Health's value.
InstituionSecurity TypeTotal SharesValue
Ra Capital Management LpCommon Shares10.2 M94.5 M
Artal Group SaCommon SharesM64.7 M
View Bellus Health Diagnostics

Bellus Health Risk Profiles

Investors will always prefer to have the highest possible return on investment while minimizing volatility. Bellus Health market risk premium is the additional return an investor will receive from holding Bellus Health long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Bellus Health. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Bellus Health's alpha and beta are two of the key measurements used to evaluate Bellus Health's performance over the market, the standard measures of volatility play an important role as well.

Bellus Stock Against Markets

Picking the right benchmark for Bellus Health stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Bellus Health stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Bellus Health is critical whether you are bullish or bearish towards Bellus Health at a given time.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Bellus Health without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Portfolio File Import Now

   

Portfolio File Import

Quickly import all of your third-party portfolios from your local drive in csv format
All  Next Launch Module

Bellus Health Corporate Directors

Bellus Health corporate directors refer to members of a Bellus Health board of directors. The board of directors generally takes responsibility for the Bellus Health's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Bellus Health's board members must vote for the resolution. The Bellus Health board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
Mahtani Bhagwandas - Independent Non-Executive DirectorProfile
Jerry Vilakazi - Non-Executive Independent DirectorProfile
Gary Harlow - Independent Non-Executive DirectorProfile
Dean Suntup - Financial Director, DirectorProfile

Invested in Bellus Health?

The danger of trading Bellus Health is mainly related to its market volatility and company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Bellus Health is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Bellus Health. The Shape ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Bellus Health is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Continue to Trending Equities. You can also try Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.

Complementary Tools for analysis

When running Bellus Health price analysis, check to measure Bellus Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bellus Health is operating at the current time. Most of Bellus Health's value examination focuses on studying past and present price action to predict the probability of Bellus Health's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Bellus Health's price. Additionally, you may evaluate how the addition of Bellus Health to your portfolios can decrease your overall portfolio volatility.
Fundamental Analysis
View fundamental data based on most recent published financial statements
Go
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Go
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Go
Transaction History
View history of all your transactions and understand their impact on performance
Go
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Go
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Go
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Go
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Go
Is Bellus Health's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bellus Health. If investors know Bellus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bellus Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Bellus Health is measured differently than its book value, which is the value of Bellus that is recorded on the company's balance sheet. Investors also form their own opinion of Bellus Health's value that differs from its market value or its book value, called intrinsic value, which is Bellus Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bellus Health's market value can be influenced by many factors that don't directly affect Bellus Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bellus Health's value and its price as these two are different measures arrived at by different means. Investors typically determine Bellus Health value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bellus Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.